Connect with us

Health

B.C. reports 471 new COVID-19 cases, six more deaths – Global News

Published

 on


British Columbia reported 471 new cases of COVID-19 Friday, along with six additional deaths.

It came as the province released new modelling showing an improved case trendline, but extended restrictions on events and social gatherings, in-person worship and sports indefinitely.

“Between now and the end of the month, we will be continually reconsidering the need for the restrictions based on incidence and prevalence of the virus, new information about transmission, especially understanding the impact of variants, and the progress of vaccine supply and our immunization program,” health officials said in a written statement.

Read more:
Coronavirus: B.C.’s ban on social gatherings and events extended until further notice

The number of patients in hospital dropped to 253 — 70 of whom were in critical or intensive care.

Story continues below advertisement

There were 4,423 active cases, while another 6,886 people were in isolation due to possible exposure.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Of the new cases, 108 were in the Vancouver Coastal Health region, 208 were in the Fraser Health region, 28 were on Vancouver Island, 56 were in the Interior Health region and 71 were in the Northern Health region.

Story continues below advertisement

A geographic breakdown by local health area released this week showed significant improvement on per-capita cases in parts of the north coast and the Interior, while parts of Vancouver Island and the Lower Mainland trended in the wrong direction.

Move slider to see week-to-week changes

According to the BC Centre for Disease Control, the province’s test-positivity rate remains at about 5.3 per cent, though it climbed to 13.7 per cent in the Northern Health region.

Story continues below advertisement

The province has administered 149,564 doses of COVID-19 vaccine — 10,366 of which were second doses.

About 90 per cent of B.C.’s 69,716 total cases have recovered, while 1,246 people have died.

As of Jan. 23, 72 per cent of B.C.’s pandemic-related fatalities were related to care-home outbreaks.

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

A look at COVID-19 vaccinations in Canada on Thursday, March 4, 2021 – GuelphToday

Published

 on


The latest numbers on COVID-19 vaccinations in Canada as of 4 a.m. ET on Thursday, March 4, 2021.

In Canada, the provinces are reporting 77,572 new vaccinations administered for a total of 2,091,700 doses given. The provinces have administered doses at a rate of 5,519.103 per 100,000.

There were 129,330 new vaccines delivered to the provinces and territories for a total of 2,611,680 doses delivered so far. The provinces and territories have used 80.09 per cent of their available vaccine supply.

Please note that Newfoundland, P.E.I., Nova Scotia, New Brunswick and the territories typically do not report on a daily basis.

Newfoundland is reporting 4,472 new vaccinations administered over the past seven days for a total of 24,757 doses given. The province has administered doses at a rate of 47.279 per 1,000. There were 1,800 new vaccines delivered to Newfoundland for a total of 35,620 doses delivered so far. The province has received enough of the vaccine to give 6.8 per cent of its population a single dose. The province has used 69.5 per cent of its available vaccine supply.

P.E.I. is reporting 966 new vaccinations administered over the past seven days for a total of 12,596 doses given. The province has administered doses at a rate of 79.405 per 1,000. There were zero new vaccines delivered to P.E.I. for a total of 14,715 doses delivered so far. The province has received enough of the vaccine to give 9.3 per cent of its population a single dose. The province has used 85.6 per cent of its available vaccine supply.

Nova Scotia is reporting 6,054 new vaccinations administered over the past seven days for a total of 35,291 doses given. The province has administered doses at a rate of 36.163 per 1,000. There were zero new vaccines delivered to Nova Scotia for a total of 61,980 doses delivered so far. The province has received enough of the vaccine to give 6.4 per cent of its population a single dose. The province has used 56.94 per cent of its available vaccine supply.

New Brunswick is reporting 7,424 new vaccinations administered over the past seven days for a total of 33,741 doses given. The province has administered doses at a rate of 43.255 per 1,000. There were zero new vaccines delivered to New Brunswick for a total of 46,775 doses delivered so far. The province has received enough of the vaccine to give 6.0 per cent of its population a single dose. The province has used 72.13 per cent of its available vaccine supply.

Quebec is reporting 17,382 new vaccinations administered for a total of 472,710 doses given. The province has administered doses at a rate of 55.245 per 1,000. There were 100,620 new vaccines delivered to Quebec for a total of 638,445 doses delivered so far. The province has received enough of the vaccine to give 7.5 per cent of its population a single dose. The province has used 74.04 per cent of its available vaccine supply.

Ontario is reporting 27,398 new vaccinations administered for a total of 754,419 doses given. The province has administered doses at a rate of 51.359 per 1,000. There were zero new vaccines delivered to Ontario for a total of 903,285 doses delivered so far. The province has received enough of the vaccine to give 6.1 per cent of its population a single dose. The province has used 83.52 per cent of its available vaccine supply.

Manitoba is reporting 1,966 new vaccinations administered for a total of 80,171 doses given. The province has administered doses at a rate of 58.221 per 1,000. There were 8,190 new vaccines delivered to Manitoba for a total of 116,650 doses delivered so far. The province has received enough of the vaccine to give 8.5 per cent of its population a single dose. The province has used 68.73 per cent of its available vaccine supply.

Saskatchewan is reporting 1,361 new vaccinations administered for a total of 81,597 doses given. The province has administered doses at a rate of 69.20 per 1,000. There were zero new vaccines delivered to Saskatchewan for a total of 74,605 doses delivered so far. The province has received enough of the vaccine to give 6.3 per cent of its population a single dose. The province has used 109.4 per cent of its available vaccine supply.

Alberta is reporting 10,229 new vaccinations administered for a total of 255,283 doses given. The province has administered doses at a rate of 57.992 per 1,000. There were zero new vaccines delivered to Alberta for a total of 274,965 doses delivered so far. The province has received enough of the vaccine to give 6.2 per cent of its population a single dose. The province has used 92.84 per cent of its available vaccine supply.

British Columbia is reporting 6,627 new vaccinations administered for a total of 289,809 doses given. The province has administered doses at a rate of 56.476 per 1,000. There were 18,720 new vaccines delivered to British Columbia for a total of 382,740 doses delivered so far. The province has received enough of the vaccine to give 7.5 per cent of its population a single dose. The province has used 75.72 per cent of its available vaccine supply.

Yukon is reporting 990 new vaccinations administered for a total of 18,158 doses given. The territory has administered doses at a rate of 435.12 per 1,000. There were zero new vaccines delivered to Yukon for a total of 18,900 doses delivered so far. The territory has received enough of the vaccine to give 45 per cent of its population a single dose. The territory has used 96.07 per cent of its available vaccine supply.

The Northwest Territories are reporting zero new vaccinations administered for a total of 19,775 doses given. The territory has administered doses at a rate of 438.285 per 1,000. There were zero new vaccines delivered to the Northwest Territories for a total of 19,100 doses delivered so far. The territory has received enough of the vaccine to give 42 per cent of its population a single dose. The territory has used 103.5 per cent of its available vaccine supply.

Nunavut is reporting 5,327 new vaccinations administered for a total of 13,393 doses given. The territory has administered doses at a rate of 345.84 per 1,000. There were zero new vaccines delivered to Nunavut for a total of 23,900 doses delivered so far. The territory has received enough of the vaccine to give 62 per cent of its population a single dose. The territory has used 56.04 per cent of its available vaccine supply.

*Notes on data: The figures are compiled by the COVID-19 Open Data Working Group based on the latest publicly available data and are subject to change. Note that some provinces report weekly, while others report same-day or figures from the previous day. Vaccine doses administered is not equivalent to the number of people inoculated as the approved vaccines require two doses per person. The vaccines are currently not being administered to children under 18 and those with certain health conditions. In some cases the number of doses administered may appear to exceed the number of doses distributed as some provinces have been drawing extra doses per vial.

This report was automatically generated by The Canadian Press Digital Data Desk and was first published March 4, 2021.

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Federal panel recommends 4-month gap between COVID vaccine doses due to limited supply – Terrace Standard – Terrace Standard

Published

 on


The National Advisory Committee on Immunization (NACI) is supporting B.C.’s decision to delay the second doses of COVID-19 vaccines by up to four months.

“NACI recommends that in the context of limited COVID-19 vaccine supply jurisdictions should maximize the number of individuals benefiting from the first dose of vaccine by extending the second dose of COVID-19 vaccine up to four months after the first,” the committee said in a decision published Wednesday (March 3).

The recommendation applies to all COVID-19 vaccines currently approved in Canada; Pfizer-BioNTech, Moderna and the newly approved AstroZeneca vaccine.

B.C. announced the decision to delay the second booster shot for four months on Monday, which health officials said could mean that all adults in the province could have their first dose by July.

READ MORE: Most B.C. adults could get their first COVID vaccine shot by July: health officials

Both provincial health officer Dr. Bonnie Henry and NACI said that its rationale was based on both the current available vaccine supply and data from other countries.

A study published by the University of Cambridge in the U.K., which has not yet been peer-reviewed, suggests that a single dose of the Pfizer-BioNTech vaccine can reduce the number of asymptomatic COVID-19 infections by 75 per cent.

In Israel, researchers studied the effects of a single dose of the same vaccine and published their findings in The Lancet medical journal, concluding that it was 85 per cent effective against symptomatic COVID-19 infections.

Also in The Lancet, a U.K. study found that the Oxford-AstraZeneca vaccine is 81 per cent effective when its second dose is given three months after the first, compared with 55 per cent efficacy after six weeks.

The national advisory committee noted that since the COVID-19 vaccines are still new, its unknown how long the protection of one or both doses lasts for.

“Experience with other multi-dose vaccines after a single dose suggests persistent protection could last for six months or longer in adolescents and adults,” NACI said in its statement. “Longer-term follow-up of clinical trial participants and those receiving vaccination in public programs will assist in determining the duration of protection following both one and two doses of vaccination.”

The national advisory committee added that it’s unknown how a delayed booster shot regime will affect the spread of variants of concern, including the U.K. and South African ones. However, NACI notes that there is “currently no evidence that an extended interval between doses will either increase or decrease the emergence of variants of concern.”

The committee noted that all three currently approved vaccines have shown “promising early result” against the U.K. variant B.1.1.7.

READ MORE: COVID-19 wage and rent subsidies, lockdown support to be extended until June

– with files from The Canadian Press


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada vaccine panel recommends 4 months between COVID doses – ABC News

Published

 on


TORONTO — A national panel of vaccine experts in Canada recommended Wednesday that provinces extend the interval between the two doses of a COVID-19 shot to four months to quickly inoculate more people amid a shortage of doses in Canada.

A number of provinces said they would do just that.

Second doses would begin to be administered in July as more shipments arrive, the panel said, noting that 55 million doses are expected to be delivered in July, August and September.

In comparison, the federal government previously said 38% of people would receive two doses by the end of June.

“They are making, I think, a reasonable calculation in a time of drug shortage,” said Dr. Andrew Morris, a professor of infectious diseases at the University of Toronto and the medical director of the Antimicrobial Stewardship Program at Sinai-University Health Network. “It’s the right decision in my mind. Let me ask … A couple are given two vaccines. Do you give two to one, or give one each one dose? It’s a no brainer.”

The addition of the newly approved AstraZeneca vaccine to the country’s supply could mean almost all Canadians would get their first shot in that time frame.

“The vaccine effectiveness of the first dose will be monitored closely and the decision to delay the second dose will be continuously assessed based on surveillance and effectiveness data and post-implementation study designs,” the panel wrote.

“Effectiveness against variants of concern will also be monitored closely, and recommendations may need to be revised,” it said, adding there is currently no evidence that a longer interval will affect the emergence of the variants.

The updated guidance applies to all three of the vaccines currently approved for use in Canada.

Manitoba and Quebec also said Wednesday they will delay second doses. And Ontario’s health minister said it would Ontario to rapidly accelerate its vaccine rollout.

Earlier Wednesday, Trudeau said any change in public health guidance regarding the timing of the two doses could affect the speed of Canada’s vaccine rollout, as could the approval of more vaccines like Johnson and Johnson.

Canada’s provinces administer health care in the country so it’s ultimately up to the provinces.

Dr. Brad Wouters, executive vice-president of science and research at University Health Network, cast doubt on the recommendation. “Nobody in the world has been 4 months between doses. These are RNA vaccines never used before. We should use evidence to make decisions. Canada conducting a population experiment,” Wouters tweeted.

And Mona Nemer, the federal government’s Chief Science Advisor, also said this week that the plan amounts to a “population-level experiment” and that the data provided so far by Moderna and Pfizer-BioNTech is based on an interval of three to four weeks between doses.

But Dr. Bonnie Henry, British Columbia’s provincial health officer, said the manufacturers structured their clinical trials that way to get the vaccines to market as quickly as possible, but said research in British Columbia, Quebec, Israel and the United Kingdom has shown that first doses are highly effective.

Dr. Supriya Sharma, chief medical adviser for Health Canada, the country’s regulator, told the Canadian Broadcasting Corporation in a time of limited supply they are starting to have greater comfort with the idea of waiting for the second dose after seeing real world data versus the strict interpretation of the clinical trials.

“In the real world we’re starting to see evidence from other countries that have delayed that second dose ‘Oh, it looks like they still have a really good effectiveness.’ We have lab studies that show it’s unlikely that immune response will drop off,” Sharma said.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending